High level discussion on “Next Generation of Infection Prevention”

High level discussion on “Next Generation of Infection Prevention” within the framework of the “Make in India” program
High level discussion on “Next Generation of Infection Prevention” within the framework of the “Make in India” program
High level discussion on “Next Generation of Infection Prevention” within the framework of the “Make in India” program
High level discussion on “Next Generation of Infection Prevention” within the framework of the “Make in India” program

New Delhi, 27 September 2016

Business France has successfully organized two interactive sessions for the French company Schülke, 100% subsidiary of Air Liquide Group on “Next Generation of Infection Prevention” within the framework of the “Make in India” program. The seminar was held in the presence of H.E Mr Alexander ZIEGLER, Ambassador of France in India at the Residence of France in New Delhi on Tuesday, on 27th September and the second one was held at the hotel Taj Coromandel, Chennai on 29th September with the participation of the Consul General of France in Pondicherry.

This event shaped an Indo-French discussion & created awareness on important topics; nosocomial infections, health care guidelines, desired standards of hospital hygiene & infection control and efficiency & application of next generation products.

The discussion also highlighted french creativity via the launch of innovative products in the area of healthcare by Schülke and celebrated the success of their flagship brand Microshield, a product which is well known among healthcare professionals in India and has been in existence for 25 years.

The interactive sessions gathered together more than a 100 participants; senior Indian government officials, medical directors & CEO’s from public and private hospitals, senior healthcare professionals and the Indian & French business communities respectively.

The dual seminars concretely demonstrated the initiatives taken by French companies to bring the most recent technologies available in Europe to India, to adapt them to the Indian context and manufacture them in India to benefit the larger interests of the healthcare sector in India.

Last modified on 06/10/2016

top of the page